Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biofrontera (BFRIW) Net Margin (2020 - 2025)

Historic Net Margin for Biofrontera (BFRIW) over the last 6 years, with Q3 2025 value amounting to 95.15%.

  • Biofrontera's Net Margin fell 322400.0% to 95.15% in Q3 2025 from the same period last year, while for Sep 2025 it was 47.28%, marking a year-over-year decrease of 109800.0%. This contributed to the annual value of 47.58% for FY2024, which is 115000.0% up from last year.
  • As of Q3 2025, Biofrontera's Net Margin stood at 95.15%, which was down 322400.0% from 58.96% recorded in Q2 2025.
  • Over the past 5 years, Biofrontera's Net Margin peaked at 57.03% during Q1 2022, and registered a low of 369.45% during Q3 2021.
  • Moreover, its 5-year median value for Net Margin was 62.53% (2021), whereas its average is 74.61%.
  • Per our database at Business Quant, Biofrontera's Net Margin tumbled by -2776600bps in 2021 and then skyrocketed by 3100800bps in 2022.
  • Quarter analysis of 5 years shows Biofrontera's Net Margin stood at 158.21% in 2021, then soared by 83bps to 27.45% in 2022, then soared by 221bps to 33.28% in 2023, then tumbled by -133bps to 11.12% in 2024, then tumbled by -756bps to 95.15% in 2025.
  • Its Net Margin was 95.15% in Q3 2025, compared to 58.96% in Q2 2025 and 48.94% in Q1 2025.